HIGHFDA DRUG

Park Avenue Compounding Phenylephrine HCI Syringes Recalled Over CGMP Violations

Park Avenue Compounding recalled 858 syringes of Phenylephrine HCI on September 17, 2025, due to CGMP deviations. The recall affects syringes with Lot # 20250813-13D65E and an expiration date of February 9, 2026. Consumers must stop using the product immediately and consult healthcare providers for further guidance.

Official notice
Park Avenue CompoundingHealth & Personal CareDrugs & MedicationsLot # 20250813-13D65EExp Date: FEB-09-2026.

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
September 17, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
September 17, 2025
Hazard Level
HIGH
Brand
Park Avenue Compounding
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Park Avenue Compounding
Product type
Phenylephrine HCI Syringe
Model numbers
Lot # 20250813-13D65E, Exp Date: FEB-09-2026.
Sold at
Multiple Retailers
Where affected
MO

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    September 17, 2025

  2. Reported by FDA DRUG

    December 10, 2025

  3. RecallRadar source check

    December 17, 2025

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

CGMP Deviations

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Park Avenue Compounding or your healthcare provider for guidance. Notification method: Letter

About This Product

Phenylephrine HCI is a medication commonly used as a decongestant. It is often prescribed for nasal congestion due to colds or allergies.

Why This Is Dangerous

CGMP deviations may indicate that the product was not manufactured under proper regulations, potentially affecting its safety and efficacy.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

The recall affects a small quantity of syringes, but it poses a high risk due to the potential for improper manufacturing.

Practical Guidance

How to identify if yours is affected

  1. Check the lot number on your syringes.
  2. Verify the expiration date which is February 9, 2026.
  3. Contact your healthcare provider for assistance.

Where to find product info

The lot number can typically be found on the packaging or label of the syringe.

What timeline to expect

Expect a response within a few weeks regarding the recall process.

If the manufacturer is unresponsive

  • Keep records of your correspondence with the company.
  • Contact the FDA if you do not receive a timely response.

How to prevent similar issues

  • Look for CGMP certifications when selecting medical products.
  • Consult healthcare providers before using unfamiliar medications.
  • Research recalls before using new medications.

Documentation advice

Keep all correspondence, receipts, and labels related to the product for your records.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

The recall involves Phenylephrine HCI, 1000 mcg / 10 mL syringes. The product is sold by Park Avenue Compounding, located at 3662 Park Ave, Saint Louis, MO 63110-2512. It falls under the NDC 83863-0104-1.

Key Facts

  • Lot # 20250813-13D65E
  • Expiration date: FEB-09-2026
  • Stop using immediately
  • Contact healthcare provider for guidance

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product TypePhenylephrine HCI Syringe
Sold At
Multiple Retailers

Product Details

Model Numbers
Lot # 20250813-13D65E
Exp Date: FEB-09-2026.
Affected States
MO
Report Date
December 10, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more